Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Sichuan Biokin Pharmaceutical Co Ltd

688506:SHH

Sichuan Biokin Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)186.68
  • Today's Change5.18 / 2.85%
  • Shares traded1.14m
  • 1 Year change+108.70%
  • Beta--
Data delayed at least 15 minutes, as of Nov 01 2024 05:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beijing Tiantan Biological Products Corp5.23bn1.27bn42.93bn4.86k33.694.03--8.210.64440.64442.655.380.34710.8137198.921,076,946.0011.4711.7116.7516.5054.2349.3933.0527.713.31--0.004616.6721.5712.0625.9916.8529.6738.97
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd76.39bn3.42bn43.39bn28.05k13.411.27--0.5682.112.1146.9922.280.99466.074.602,723,576.004.715.908.9312.4016.5518.704.745.561.15--0.31730.026.6812.322.253.3427.7512.05
Beijing Tongrentang Co Ltd17.96bn1.63bn54.93bn16.78k33.734.23--3.061.191.1913.099.460.59121.0811.141,070,467.007.888.2015.6316.1744.4846.5913.3313.331.58--0.176530.9316.194.6816.928.03-12.0113.97
Shanghai Fosun Pharmaceutical (Group)41.61bn2.11bn64.05bn40.37k33.851.51--1.540.78830.788315.5417.710.36822.865.101,030,748.002.444.314.187.0147.1050.716.6310.650.7221--0.375531.92-5.8110.69-36.04-2.5010.95-3.34
Sichuan Biokin Pharmaceutical Co Ltd5.85bn3.80bn71.75bn2.09k18.8816.92--12.279.489.4814.5810.581.401.8164.162,802,843.0090.79--138.20--95.33--64.99--2.89--0.2807---20.11---176.40------
Beijing Wantai Biolog Pha Ent Co Ltd2.49bn-294.04m90.95bn3.84k--7.32--36.53-0.2393-0.23931.979.820.15960.78430.7758647,931.10-1.8924.08-2.2631.8069.0185.18-11.8434.954.18--0.02389.88-50.7341.18-73.6533.6136.35--
Data as of Nov 01 2024. Currency figures normalised to Sichuan Biokin Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

32.24%Per cent of shares held by top holders
HolderShares% Held
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20246.74m7.45%
China Asset Management Co., Ltd.as of 30 Jun 20245.42m5.99%
GF Fund Management Co., Ltd.as of 30 Jun 20245.21m5.76%
E Fund Management Co., Ltd.as of 30 Jun 20244.43m4.90%
China Universal Asset Management Co., Ltd.as of 30 Jun 20242.24m2.47%
JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 20241.42m1.57%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20241.15m1.27%
Penghua Fund Management Co., Ltd.as of 30 Jun 20241.09m1.20%
Bank of China Investment Management Co., Ltd.as of 30 Jun 2024790.41k0.87%
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024683.64k0.76%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.